CSIMarket



Boston Scientific Corporation  (BSX)
Other Ticker:  
 
 

BSX's Capital Expenditures Growth by Quarter and Year

Boston Scientific's Capital Expenditures results by quarter and year




BSX Capital Expenditures (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 266.00 159.00 186.00
III Quarter September - 107.00 49.00 121.00
II Quarter June - 106.00 68.00 -162.00
I Quarter March 121.00 75.00 100.00 106.00
FY   121.00 554.00 376.00 251.00



BSX Capital Expenditures first quarter 2022 Y/Y Growth Comment
Boston Scientific Corporation achieved in the first quarter 2022, above Company average Capital Expenditures rise of 61.33% year on year, to $ 121.00 millions.

Looking into first quarter 2022 results within Medical Equipment & Supplies industry 32 other companies have achieved higher Capital Expenditures growth. While Boston Scientific Corporation' s Capital Expenditures jump of 61.33% ranks overall at the positon no. 779 in the first quarter 2022.




BSX Capital Expenditures ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - 67.3 % -14.52 % 144.74 %
III Quarter September - 118.37 % -59.5 % 63.51 %
II Quarter June - 55.88 % - -
I Quarter March 61.33 % -25 % -5.66 % 34.18 %
FY   - 47.34 % 49.8 % -13.15 %

Financial Statements
Boston Scientific's first quarter 2022 Capital Expenditures $ 121.00 millions BSX's Income Statement
Boston Scientific's first quarter 2021 Capital Expenditures $ 75.00 millions Quarterly BSX's Income Statement
New: More BSX's historic Capital Expenditures Growth >>


BSX Capital Expenditures (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - 148.6 % 224.49 % 53.72 %
III Quarter September - 0.94 % -27.94 % -
II Quarter June - 41.33 % -32 % -
I Quarter March -54.51 % -52.83 % -46.24 % 39.47 %
FY (Year on Year)   - 47.34 % 49.8 % -13.15 %




Capital Expenditures first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #33
Healthcare Sector #113
Overall #779

Capital Expenditures Y/Y Growth Statistics
High Average Low
1130.51 % 32.69 % -99.05 %
(Dec. 31, 2009)   (Mar 31 2019)
Capital Expenditures first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #33
Healthcare Sector #113
Overall #779
Capital Expenditures Y/Y Growth Statistics
High Average Low
1130.51 % 32.69 % -99.05 %
(Dec. 31, 2009)   (Mar 31 2019)

Capital Expenditures by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Boston Scientific's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
224.49 % 12.42 % -78.29 %
(Dec 31 2020)  


BSX's I. Quarter Q/Q Capital Expenditures Comment
In the I. Quarter 2022 Boston Scientific Corporation reported fall in Capital Expenditures sequentially by -54.51% to $ 121.00 millions, from $ 266.00 millions released in the previous reporting period.

This is not important issue, as Boston Scientific's Capital Expenditures always gravitate to dip in this quarter Malte Pettersson, an industry researcher told.

Within Medical Equipment & Supplies industry 60 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Boston Scientific's Capital Expenditures growth quarter on quarter, overall rank is 1634.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #61
Healthcare Sector #240
Overall #1634
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #61
Healthcare Sector #240
Overall #1634
Capital Expenditures Q/Q Growth Statistics
High Average Low
224.49 % 12.42 % -78.29 %
(Dec 31 2020)  


BSX's I. Quarter Q/Q Capital Expenditures Comment
In the I. Quarter 2022 Boston Scientific Corporation disclosed fall in Capital Expenditures from the forth quarter by -54.51% to $ 121.00 millions, from $ 266.00 millions achived in the previous reporting period.

This is not huge concern, as Boston Scientific's Capital Expenditures frequently gravitate to dip in this quarter Malte Pettersson, an industry researcher noted.

Within Medical Equipment & Supplies industry 60 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Boston Scientific's Capital Expenditures growth quarter on quarter, overall rank is 1634.


Boston Scientific's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Capital Expenditures 12 Months Ending $ 600.00 $ 554.00 $ 447.00 $ 389.00 $ 351.00
Y / Y Capital Expenditures Growth (TTM) 70.94 % 47.34 % 10.92 % -18.11 % -29.52 %
Year on Year Capital Expenditures Growth Overall Ranking # 488 # 369 # 1015 # 1777 # 1027
Seqeuential Capital Expenditures Change (TTM) 8.3 % 23.94 % 14.91 % 10.83 % -6.65 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 779 # 294 # 1029 # 1134 # 1952




Cumulative Capital Expenditures growth Comment
Although Boston Scientific's Annual Capital Expenditures growth year on year were below company's average 529.67% , Capital Expenditures announced in the Mar 31 2022 period, show improvement in Capital Expenditures trend, to cumulative trailing twelve month growth of 70.94% year on year, from 47.34% in Dec 31 2021.

In the Healthcare sector 83 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 369 to 488.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
1130.51 %
32.69 %
-99.05 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 33
Healthcare Sector # 84
Overall # 488

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
16500 %
529.67 %
-98.88 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 33
Sector # 113
S&P 500 # 779
Cumulative Capital Expenditures growth Comment
Although Boston Scientific's Annual Capital Expenditures growth year on year were below company's average 529.67% , Capital Expenditures announced in the Mar 31 2022 period, show improvement in Capital Expenditures trend, to cumulative trailing twelve month growth of 70.94% year on year, from 47.34% in Dec 31 2021.

In the Healthcare sector 83 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 369 to 488.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
1130.51 %
32.69 %
-99.05 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 33
Healthcare Sector # 84
Overall # 488

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
16500 %
529.67 %
-98.88 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 33
Sector # 113
S&P 500 # 779




Other Capital Expenditures Growth
Medical Equipment & Supplies Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
BSX's Capital Expenditures Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for BSX's Competitors
Capital Expenditures Growth for Boston Scientific's Suppliers
Capital Expenditures Growth for BSX's Customers

You may also want to know
BSX's Annual Growth Rates BSX's Profitability Ratios BSX's Asset Turnover Ratio BSX's Dividend Growth
BSX's Roe BSX's Valuation Ratios BSX's Financial Strength Ratios BSX's Dividend Payout Ratio
BSX's Roa BSX's Inventory Turnover Ratio BSX's Growth Rates BSX's Dividend Comparisons



Companies with similar Capital Expenditures fall for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Mar 31 2022
National Healthcare Corp107.12%$ 107.118 millions
Aerie Pharmaceuticals Inc 106.87%$ 106.865 millions
National Research Corporation105.33%$ 105.331 millions
Veracyte Inc 105.10%$ 105.100 millions
Align Technology inc 101.07%$ 101.073 millions
Lexicon Pharmaceuticals Inc 100.00%$ 100.000 millions
Aspira Women s Health Inc 100.00%$ 100.000 millions
Protagonist Therapeutics inc 95.00%$ 95.000 millions
Akebia Therapeutics Inc 93.22%$ 93.220 millions
Wave Life Sciences Ltd 92.59%$ 92.593 millions
Regulus Therapeutics Inc 92.45%$ 92.453 millions
Hologic Inc91.19%$ 91.192 millions
Pacific Health Care Organization Inc.89.64%$ 89.641 millions
Conformis inc 89.59%$ 89.589 millions
Apollo Endosurgery inc 85.52%$ 85.522 millions
Oncocyte Corporation85.39%$ 85.392 millions
Harrow Health Inc 83.04%$ 83.036 millions
Gritstone Bio Inc 83.03%$ 83.030 millions
Orasure Technologies Inc82.80%$ 82.795 millions
Universal Biosensors Inc81.48%$ 81.479 millions
Resmed Inc 78.96%$ 78.963 millions
Ngm Biopharmaceuticals Inc 78.13%$ 78.125 millions
Agile Therapeutics Inc77.46%$ 77.465 millions
Alimera Sciences Inc 77.38%$ 77.381 millions
Surmodics Inc 76.61%$ 76.606 millions
Reneo Pharmaceuticals Inc 76.00%$ 76.000 millions
Actinium Pharmaceuticals Inc 75.00%$ 75.000 millions
Ocular Therapeutix Inc 74.68%$ 74.684 millions
Tivity Health Inc 73.93%$ 73.927 millions
Axogen inc 72.78%$ 72.778 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

EOSS's Profile

Stock Price

EOSS's Financials

Business Description

Fundamentals

Charts & Quotes

EOSS's News

Suppliers

EOSS's Competitors

Customers & Markets

Economic Indicators

EOSS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071